Timothy Mosmann
15Patents
6h-index
12Co-inventors
59Inventor score
Filing activity: Mar 25, 1986 → Jun 6, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5017691A | Mammalian interleukin-4 | Chemistry; Metallurgy | 151 | Expired |
| US5231012A | Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10) | Emerging Cross-Sectional Technologies | 81 | Expired |
| US6217857A | Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5955315A | Nucleic acids encoding human interleukin-4 | Chemistry; Metallurgy | 12 | Expired |
| US5518882A | Immunological methods of component selection and recovery | Physics | 9 | Expired |
| US6018036A | Nucleic acids encoding cytokine synthesis inhibitory factor (Interleukin-10) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5951973A | Use of interleukin-4 (IL-4) to treat rheumatoid arthritis | Chemistry; Metallurgy | 5 | Expired |
| US6207154A | Methods of treatment using antagonists of cytokine synthesis inhibitory factor | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5552304A | CDNA Clones coding for human protein exhibiting a broad cellular activity spectrum (human interleukin-4) | Chemistry; Metallurgy | 2 | Expired |
| US6239260A | Binding compositions specific for interleukin-10 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6312680A | Methods of treatment using cytokine synthesis inhibitory factor | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5136022A | T cell activation markers | Chemistry; Metallurgy | 1 | Expired |
| US5730970A | Pharmaceutical compositions comprising human interleukin-4 (IL-4) | Chemistry; Metallurgy | 0 | Expired |
| US5656266A | Method of using interleukin-4 | Chemistry; Metallurgy | 0 | Expired |
| US5807996A | Fused polypeptides comprising interleukin-4 polypeptide fragments | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.